Skip to main content
SpringerLink
Log in

Epidemiology of Cholangiocarcinoma and Gallbladder Carcinoma

  • Chapter
  • First Online:
Biliary Tract and Gallbladder Cancer

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Cholangiocarcinoma (CCA) and gallbladder carcinoma (GBCA) are rare but lethal cancers of the liver and biliary tract. While surgical resection offers the best chance for cure, many cancers present late in the disease course when surgery does not alter patient survival or quality of life and is often unable to achieve a margin-negative (R0) resection. Despite advances in imaging and diagnostic modalities, appropriate screening protocols are yet to be developed due to the lack of known and modifiable risk factors. This chapter describes the epidemiology of cholangiocarcinoma and gallbladder carcinoma across world populations. Special attention is paid to describing the incidence, prevalence, and mortality of cholangiocarcinoma in the high-risk populations from Thailand, Japan, Korea, and China where infection with the liver flukes, O. viverrini and C. sinensis, and positive Hepatitis B and C infection are strongly implicated in CCA development. Intrahepatic stones, primary sclerosing cholangitis (PSC), biliary tree infection, and altered bilio-pancreatic anatomy may contribute to a chronic inflammatory state that promotes biliary epithelial metaplasia and CCA. In the last 10 – 15 years, there has been a trend of increased intrahepatic cholangiocarcinoma (ICC) and concurrent decreased extrahepatic cholangiocarcinoma (ECC) incidence, especially in low-risk populations of the United States, Europe, and Scandinavia. Gallbladder carcinoma incidence and mortality continues to be high in populations from northern India, Pakistan, and Eastern Europe, and is disproportionally higher in women. While the overall recent trend of GBCA incidence and mortality is on the decline, it remains high in women of high Amerindian ethnicity in South America and the United States. The differential decreased mortality in populations from the United States, Europe, and Scandinavia compared to South America and Asia is attributed to differential access and utilization of cholecystectomy. Specific risk factors for GBCA include longstanding cholelithiasis, S. typhi infection / chronic carrier state, and polypoid lesions of the gallbladder. However, these are not sensitive or specific modifiable risk factors are limited, thereby restricting the ability to design a screening protocol or mandate prophylactic surgery to protect against GBCA. Ongoing research efforts are focusing on the multifactorial contributions of environmental toxins, diet, obesity, and molecular mechanisms of CCA and GBCA development to improve early diagnosis and develop targeted therapies to complement surgical resection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. de Groen PC et al (1999) Biliary tract cancers. N Engl J Med 341(18):1368–1378

    PubMed  Google Scholar 

  2. Blechacz BR, Gores GJ (2008) Cholangiocarcinoma. Clin Liver Dis 12(1):131–150 (ix)

    PubMed  Google Scholar 

  3. SEER, S.R.P. (2012) National Cancer Institute SEER/Stat software, version 7.0.4., SEER Cancer Stat Rev, 1975–2009 (Vintage 2009)

    Google Scholar 

  4. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30

    PubMed  Google Scholar 

  5. Parkin DM et al (2002) 2002 Cancer incidence in five continents, VIII—IARC Publication No. 155, vol VIII. 2002, France (Lyon) IARC

    Google Scholar 

  6. Curado MP et al (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publication No. 160. Vol. IX. 2007, France (Lyon)

    Google Scholar 

  7. Goodman MT, Yamamoto J (2007) Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997–2002. Cancer Causes Control 18(4):415–422

    PubMed  CAS  Google Scholar 

  8. Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) (2010) WHO classification of tumours of the digestive system, 4th edn. IARC, Lyon

    Google Scholar 

  9. Hamilton SR, Aaltonen LA (eds) (2000) World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. IARC Press, Lyon

    Google Scholar 

  10. Alpini G, McGill JM, Larusso NF (2002) The pathobiology of biliary epithelia. Hepatology 35(5):1256–1268

    PubMed  CAS  Google Scholar 

  11. Sell S, Dunsford HA (1989) Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 134(6):1347–1363

    PubMed Central  PubMed  CAS  Google Scholar 

  12. O’Hara SP Tabibian PH, Splinter PL et al (2013) The dynamic biliary epithelium. J Hepatol 58(3):575–582

    Google Scholar 

  13. Albores-Saavedra J, Henson DE, Sobin LH (1991) Histological typing of gallbladder and extrahepatic bile ducts. WHO histological typing of tumors of the gallbladder and extrahepatic bile ducts. Springer, Berlin

    Google Scholar 

  14. Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38(2):241–256

    PubMed  CAS  Google Scholar 

  15. Percy C, Van Holten V, Muir C (eds) (1990) International Classification of Diseases for Oncology, 2nd edn. Geneva: WHO

    Google Scholar 

  16. Matull WR, Khan SA, Pereira SP (2007) Re: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 99(5):407–408

    PubMed  Google Scholar 

  17. Welzel TM et al (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98(12):873–875

    PubMed  Google Scholar 

  18. Fritz A, Constance P, Jack A, Shanmugaratnam K, Sobin LH, Parkin MD (eds) (2000) Internaional classification of diseases for oncology (ICD-O), 3rd edn. World Health Organization, Geneva

    Google Scholar 

  19. Nakeeb A et al (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224(4):463–473 (discussion 473–475)

    PubMed Central  PubMed  CAS  Google Scholar 

  20. IARC (1994) Schistosomes, liver flukes and helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum 60:1–560 (Lyon 7–14 June 1994)

    Google Scholar 

  21. Koga A et al (1985) Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance. Cancer 55(12):2826–2829

    PubMed  CAS  Google Scholar 

  22. Rosen CB et al (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213(1):21–25

    PubMed Central  PubMed  CAS  Google Scholar 

  23. Srivatanakul P et al (1991) Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer 48(6):821–825

    PubMed  CAS  Google Scholar 

  24. Srivatanakul P et al (1991) The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study. Cancer 68(11):2411–2417

    PubMed  CAS  Google Scholar 

  25. Khan SA, Toledano MB, Taylor-Robinson SD (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10(2):77–82

    CAS  Google Scholar 

  26. Tyson GL, El-Serag HB (2011) Risk factors for cholangiocarcinoma. Hepatology 54(1):173–184

    PubMed Central  PubMed  CAS  Google Scholar 

  27. Welzel TM et al (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5(10):1221–1228

    PubMed Central  PubMed  Google Scholar 

  28. Guglielmi A et al (2010) Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 101(2):111–115

    PubMed  Google Scholar 

  29. Nathan H et al (2007) Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg 11(11):488–496 (discussion 1496–1497)

    Google Scholar 

  30. Patel T (2002) Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2:10

    PubMed Central  PubMed  Google Scholar 

  31. Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33(6):1353–1357

    PubMed  CAS  Google Scholar 

  32. McLean L, Patel T (2006) Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int 26(9):1047–1053

    PubMed  Google Scholar 

  33. Khan SA et al (2012) Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 56(4):848–854

    PubMed  Google Scholar 

  34. Alberts SR et al (2012) Occurrence of pancreatic, biliary tract, and gallbladder cancers in Alaska Native people, 1973–2007. Int J Circumpolar Health 71:17521

    PubMed  Google Scholar 

  35. Yang JD et al (2012) Biliary tract cancers in Olmsted County, Minnesota, 1976–2008. Am J Gastroenterol 107(8):1256–1262

    PubMed Central  PubMed  Google Scholar 

  36. West J et al (2006) Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br J Cancer 94(11):1751–1758

    PubMed Central  PubMed  CAS  Google Scholar 

  37. Taylor-Robinson SD et al (1997) Increase in primary liver cancer in the UK, 1979–1994. Lancet 350(9085):1142–1143

    PubMed  CAS  Google Scholar 

  38. Taylor-Robinson SD et al (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut 48(6):816–820

    PubMed Central  PubMed  CAS  Google Scholar 

  39. Wood R et al (2003) Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer 39(14):2087–2092

    PubMed  CAS  Google Scholar 

  40. Coupland VH et al (2012) Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol 36(4):e207–e214

    PubMed  Google Scholar 

  41. Khan SA et al (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37(6):806–813

    PubMed  Google Scholar 

  42. Engholm G et al (2010) Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Materials and methods. Acta Oncol 49(5):545–560

    PubMed  Google Scholar 

  43. Klint A et al (2010) Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 49(5):578–607

    PubMed  Google Scholar 

  44. Jepsen P et al (2007) Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst 99(11):895–897

    PubMed  Google Scholar 

  45. Witjes CD et al (2012) Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival. HPB (Oxford) 14(11):777–781

    Google Scholar 

  46. Alvaro D et al (2010) Descriptive epidemiology of cholangiocarcinoma in Italy. Dig Liver Dis 42(7):490–495

    PubMed  Google Scholar 

  47. Lepage C et al (2011) Trends in the incidence and management of biliary tract cancer: a French population-based study. J Hepatol 54(2):306–310

    PubMed  Google Scholar 

  48. Boyle P, Smans M (eds) (2008) Atlas of cancer mortality in the european union and the european economic area 1993–1997—IARC Scientific Publication No. 159 IARC, France (Lyon)

    Google Scholar 

  49. Shaib YH et al (2004) Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40(3):472–477

    PubMed  Google Scholar 

  50. Keiser J, Utzinger J (2005) Emerging foodborne trematodiasis. Emerg Infect Dis 11(10):1507–1514

    PubMed Central  PubMed  Google Scholar 

  51. Bouvard V et al (2009) A review of human carcinogens–Part B: biological agents. Lancet Oncol 10(4):321–322

    PubMed  Google Scholar 

  52. Watanapa P, Watanapa WB (2002) Liver fluke-associated cholangiocarcinoma. Br J Surg 89(8):962–970

    PubMed  CAS  Google Scholar 

  53. Watanapa P (1996) Cholangiocarcinoma in patients with opisthorchiasis. Br J Surg 83(8):1062–1064

    PubMed  CAS  Google Scholar 

  54. Sripa B et al (2007) Liver fluke induces cholangiocarcinoma. PLoS Med 4(7):e201

    PubMed Central  PubMed  Google Scholar 

  55. Andoh H et al (2004) Cholangiocarcinoma coincident with schistosomiasis japonica. J Gastroenterol 39(1):64–68

    PubMed  Google Scholar 

  56. Furst T, Keiser J, Utzinger J (2012) Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 12(3):210–221

    PubMed  Google Scholar 

  57. Lun ZR et al (2005) Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 5(1):31–41

    PubMed  Google Scholar 

  58. Gores GJ (2003) Cholangiocarcinoma: current concepts and insights. Hepatology 37(5):961–969

    PubMed  Google Scholar 

  59. Malhi H, Gores GJ (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45(6):856–867

    PubMed Central  PubMed  CAS  Google Scholar 

  60. Marzioni M, Fava G, Benedetti A (2006) Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis. World J Gastroenterol 12(22):3471–3480

    PubMed  CAS  Google Scholar 

  61. Shin HR et al (2010) Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 101(3):579–585

    PubMed  CAS  Google Scholar 

  62. Shin HR et al (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 25(5):933–940

    PubMed  CAS  Google Scholar 

  63. Choi D et al (2006) Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol 44(6):1066–1073

    PubMed  Google Scholar 

  64. Lim MK et al (2006) Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg 75(1):93–96

    PubMed  Google Scholar 

  65. Shin HR et al (2010) Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea. J Korean Med Sci 25(7):1011–1016

    PubMed Central  PubMed  Google Scholar 

  66. Shin HR et al (2010) Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma-focus on East and South-Eastern Asia. Asian Pac J Cancer Prev 11(5):1159–1166

    PubMed  Google Scholar 

  67. Parkin DM et al (1993) Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomark Prev 2(6):537–544

    CAS  Google Scholar 

  68. Poomphakwaen K et al (2009) Risk factors for cholangiocarcinoma in Khon Kaen, Thailand: a nested case-control study. Asian Pac J Cancer Prev 10(2):251–258

    PubMed  Google Scholar 

  69. Pattanathien P et al (2013) Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev 14(1):321–324

    PubMed  Google Scholar 

  70. Hughes NR et al (2006) Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes. J Clin Pathol 59(10):1073–1078

    PubMed Central  PubMed  CAS  Google Scholar 

  71. Miyakawa S et al (2009) Biliary tract cancer treatment: 5,584 results from the biliary tract cancer statistics registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg 16(1):1–7

    PubMed  Google Scholar 

  72. Nagakawa T et al (2002) Biliary tract cancer treatment: results from the biliary tract cancer statistics registry in Japan. J Hepato-Biliary-Pancreatic Surg 9(5):569–575

    Google Scholar 

  73. Ishiguro S et al (2008) Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification. Cancer Causes Control 19(1):33–41

    PubMed  Google Scholar 

  74. Todani T et al (1977) Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 134(2):263–269

    PubMed  CAS  Google Scholar 

  75. Yamaguchi M (1980) Congenital choledochal cyst. Analysis of 1,433 patients in the Japanese literature. Am J Surg 140(5):653–657

    PubMed  CAS  Google Scholar 

  76. Soreide K et al (2004) Bile duct cysts in adults. Br J Surg 91(12):1538–1548

    PubMed  CAS  Google Scholar 

  77. Edil BH et al (2008) Choledochal cyst disease in children and adults: a 30-year single-institution experience. J Am Coll Surg 206(5):1000–1005

    PubMed  Google Scholar 

  78. Atkinson HD et al (2003) Choledochal cysts in adults and their complications. HPB (Oxford) 5(2):105–110

    CAS  Google Scholar 

  79. Soreide K, Soreide JA (2007) Bile duct cyst as precursor to biliary tract cancer. Ann Surg Oncol 14(3):1200–1211

    PubMed  Google Scholar 

  80. Tan SS et al (2007) Management of adult choledochal cyst. Singapore Med J 48(6):524–527

    PubMed  CAS  Google Scholar 

  81. Liu CL et al (2002) Choledochal cysts in adults. Arch Surg 137(4):465–468

    PubMed  Google Scholar 

  82. Rossi RL et al (1987) Carcinomas arising in cystic conditions of the bile ducts. A clinical and pathologic study. Ann Surg 205(4):377–384

    PubMed Central  PubMed  CAS  Google Scholar 

  83. Nagorney DM, McIlrath DC, Adson MA (1984) Choledochal cysts in adults: clinical management. Surgery 96(4):656–663

    PubMed  CAS  Google Scholar 

  84. Iwai N et al (1990) Cancer arising in a choledochal cyst in a 12-year-old girl. J Pediatr Surg 25(12):1261–1263

    PubMed  CAS  Google Scholar 

  85. Visser BC et al (2004) Congenital choledochal cysts in adults. Arch Surg 139(8):855–860 (discussion 860–862)

    PubMed  Google Scholar 

  86. de Vries JS et al (2002) Choledochal cysts: age of presentation, symptoms, and late complications related to Todani’s classification. J Pediatr Surg 37(11):1568–1573

    PubMed  Google Scholar 

  87. Fieber SS, Nance FC (1997) Choledochal cyst and neoplasm: a comprehensive review of 106 cases and presentation of two original cases. Am Surg 63(11):982–987

    PubMed  CAS  Google Scholar 

  88. Ono S et al (2008) Development of bile duct cancer in a 26-year-old man after resection of infantile choledochal cyst. J Pediatr Surg 43(6):E17–E19

    PubMed  Google Scholar 

  89. Iwai N et al (1992) Congenital choledochal dilatation with emphasis on pathophysiology of the biliary tract. Ann Surg 215(1):27–30

    PubMed Central  PubMed  CAS  Google Scholar 

  90. Sirica AE et al (2008) Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton basic research single-topic conference. Hepatology 48(6):2040–2046

    PubMed Central  PubMed  Google Scholar 

  91. Iwai N et al (1986) Biliary manometry in choledochal cyst with abnormal choledochopancreatico ductal junction. J Pediatr Surg 21(10):873–876

    PubMed  CAS  Google Scholar 

  92. Jaiswal M, LaRusso NF, Gores GJ (2001) Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 281(3):G626–G634

    PubMed  CAS  Google Scholar 

  93. Wise C et al (2008) Mechanisms of biliary carcinogenesis and growth. World J Gastroenterol 14(19):2986–2989

    PubMed Central  PubMed  CAS  Google Scholar 

  94. Tocchi A et al (2001) Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients. Ann Surg 234(2):210–214

    PubMed Central  PubMed  CAS  Google Scholar 

  95. Hakamada K et al (1997) Late development of bile duct cancer after sphincteroplasty: a ten- to twenty-two-year follow-up study. Surgery 121(5):488–492

    PubMed  CAS  Google Scholar 

  96. Strong RW (1999) Late bile duct cancer complicating biliary-enteric anastomosis for benign disease. Am J Surg 177(6):472–474

    PubMed  CAS  Google Scholar 

  97. Strong RW (1999) Does sphincteroplasty predispose to bile duct cancer? HPB Surg 11(3):204–206

    PubMed Central  PubMed  CAS  Google Scholar 

  98. Bettschart V et al (2002) Cholangiocarcinoma arising after biliary-enteric drainage procedures for benign disease. Gut 51(1):128–129

    PubMed Central  PubMed  CAS  Google Scholar 

  99. Karlson BM et al (1997) Population-based study of cancer risk and relative survival following sphincterotomy for stones in the common bile duct. Br J Surg 84(9):1235–1238

    PubMed  CAS  Google Scholar 

  100. Ando H et al (1996) Intrahepatic bile duct stenosis causing intrahepatic calculi formation following excision of a choledochal cyst. J Am Coll Surg 183(1):56–60

    PubMed  CAS  Google Scholar 

  101. Sheen-Chen S et al (2000) Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control 28(4):298–301

    PubMed  CAS  Google Scholar 

  102. Suzuki Y et al (2012) Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study. Hepatol Res 42(2):166–170

    PubMed  Google Scholar 

  103. Lee CC, Wu CY, Chen GH (2002) What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? J Gastroenterol Hepatol 17(9):1015–1020

    PubMed  Google Scholar 

  104. Su CH et al (1997) Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 84(7):969–973

    PubMed  CAS  Google Scholar 

  105. Kubo S et al (1995) Hepatolithiasis associated with cholangiocarcinoma. World J Surg 19(4):637–641

    PubMed  CAS  Google Scholar 

  106. Chen MF et al (2000) Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma. Dig Dis Sci 45(2):312–316

    PubMed  CAS  Google Scholar 

  107. Azuma T et al (1999) The significance of hepatectomy for primary intrahepatic stones. Surg Today 29(10):1004–1010

    PubMed  CAS  Google Scholar 

  108. Kim YT et al (2003) Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis. Hepatogastroenterology 50(49):8–12

    PubMed  Google Scholar 

  109. Liu ZY et al (2011) Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. Hepatobiliary Pancreat Dis Int 10(6):626–631

    PubMed  Google Scholar 

  110. Prall RT et al (2000) Current therapies and clinical controversies in the management of primary sclerosing cholangitis. Curr Gastroenterol Rep 2(2):99–103

    PubMed  CAS  Google Scholar 

  111. Bergquist A et al (1998) Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27(2):311–316

    PubMed  CAS  Google Scholar 

  112. Broomé U et al (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38(4):610–615

    PubMed Central  PubMed  Google Scholar 

  113. Wiesner RH et al (1989) Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10(4):430–436

    PubMed  CAS  Google Scholar 

  114. Ahrendt SA et al (1999) Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Surg 3(4):357–367 (discussion 367–368)

    PubMed  CAS  Google Scholar 

  115. Chapman R et al (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51(2):660–678

    PubMed  CAS  Google Scholar 

  116. Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48(1):308–321

    PubMed Central  PubMed  CAS  Google Scholar 

  117. Brandsaeter B et al (2004) Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 40(5):815–822

    PubMed  CAS  Google Scholar 

  118. Bergquist A et al (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36(3):321–327

    PubMed  Google Scholar 

  119. Lazaridis KN, Gores GJ (2006) Primary sclerosing cholangitis and cholangiocarcinoma. Semin Liver Dis 26(1):42–51

    PubMed  CAS  Google Scholar 

  120. Tischendorf JJ et al (2007) Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 102(1):107–114

    PubMed  Google Scholar 

  121. Boberg KM et al (2002) Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 37(10):1205–1211

    PubMed  CAS  Google Scholar 

  122. Kaya M et al (2001) Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience. Am J Gastroenterol 96(4):1164–1169

    PubMed  CAS  Google Scholar 

  123. Brandsaeter B et al (2003) Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol 38(11):1176–1183

    PubMed  CAS  Google Scholar 

  124. de Valle MB, Bjornsson E, Lindkvist B (2012) Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int 32(3):441–448

    PubMed  Google Scholar 

  125. Kornfeld D, Ekbom A, Ihre T (1997) Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: a population-based study. Scand J Gastroenterol 32(10):1042–1045

    PubMed  CAS  Google Scholar 

  126. Tanaka A et al (2008) Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Liver Int 28(7):983–989

    PubMed  CAS  Google Scholar 

  127. Rea DJ et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242(3):451–458 (discussion 458–461)

    PubMed Central  PubMed  Google Scholar 

  128. Brandsaeter B et al (2003) Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl 9(9):961–969

    PubMed  Google Scholar 

  129. Parkin DM et al (1991) Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 48(3):323–328

    PubMed  CAS  Google Scholar 

  130. Donato F et al (2001) Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 12(10):959–964

    PubMed  CAS  Google Scholar 

  131. Yamamoto S et al (2004) Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 95(7):592–595

    PubMed  CAS  Google Scholar 

  132. Shaib YH et al (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128(3):620–626

    PubMed  Google Scholar 

  133. El-Serag HB et al (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 49(1):116–123

    PubMed Central  PubMed  Google Scholar 

  134. Fwu CW et al (2011) Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatology 53(4):1217–1225

    PubMed  Google Scholar 

  135. Lee CH et al (2009) Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 100(11):1765–1770

    PubMed Central  PubMed  CAS  Google Scholar 

  136. Lee TY et al (2008) Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 103(7):1716–1720

    PubMed  Google Scholar 

  137. Zhou H et al (2010) Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer 46(6):1056–1061

    PubMed  CAS  Google Scholar 

  138. Li M et al (2012) Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review. J Gastroenterol Hepatol 27(10):1561–1568

    PubMed  Google Scholar 

  139. Zhou Y et al (2012) Hepatitis Viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 12:289

    PubMed Central  PubMed  Google Scholar 

  140. Tanaka M et al (2010) Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. J Viral Hepat 17(10):742–748

    PubMed Central  PubMed  CAS  Google Scholar 

  141. Shaib YH et al (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 102(5):1016–1021

    PubMed  Google Scholar 

  142. Blum HE et al (1983) Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci USA 80(21):6685–6688

    PubMed Central  PubMed  CAS  Google Scholar 

  143. Loriot MA et al (1999) Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology 29(5):1587–1595

    PubMed  CAS  Google Scholar 

  144. Jaiswal M et al (2000) Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60(1):184–190

    PubMed  CAS  Google Scholar 

  145. Cardinale V et al (2011) Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology 54(6):2159–2172

    PubMed  CAS  Google Scholar 

  146. Komuta M et al (2008) Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 47(5):1544–1556

    PubMed  CAS  Google Scholar 

  147. Zhu AX, Lauwers GY, Tanabe KK (2004) Cholangiocarcinoma in association with Thorotrast exposure. J Hepatobiliary Pancreat Surg 11(6):430–433

    PubMed  Google Scholar 

  148. IARC (2012) Radiation: a review of human carcinogens. Monographs 100-D. In: Monographs I (ed) Internalized α-particle emitting radionuclides, 2012, IARC, France (Lyon), pp 250–263

    Google Scholar 

  149. IARC (2001) Ionizing radiation, part 2: some internally deposited radionuclides. IARC monographs on the evaluation of carcinogenic risks to humans, vol 78. IARC, France (Lyon), pp 1–559 (PMID:11421248)

    Google Scholar 

  150. Ito Y (1988) Pathomorphological characteristics of thorotrast-related cholangiocarcinoma. Kurume Med J 35(2):63–69

    PubMed  CAS  Google Scholar 

  151. Ito Y et al (1988) Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 62(6):1153–1162

    PubMed  CAS  Google Scholar 

  152. Mori T, Kato Y (1991) Epidemiological, pathological and dosimetric status of Japanese thorotrast patients. J Radiat Res 32(2):34–45

    PubMed  Google Scholar 

  153. van Kaick G et al (1991) Neoplastic diseases induced by chronic alpha-irradiation-epidemiological, biophysical and clinical results of the German Thorotrast Study. J Radiat Res 32(2):20–33

    PubMed  Google Scholar 

  154. Liu D et al (2002) Microsatellite instability in thorotrast-induced human intrahepatic cholangiocarcinoma. Int J Cancer 102(4):366–371

    PubMed  CAS  Google Scholar 

  155. Donohoe CL et al (2010) Obesity and gastrointestinal cancer. Br J Surg 97(5):628–642

    PubMed  CAS  Google Scholar 

  156. Shebl FM et al (2011) Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China. Br J Cancer 105(9):1424–1429

    PubMed Central  PubMed  CAS  Google Scholar 

  157. Welzel TM et al (2007) Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer 120(3):638–641

    PubMed  CAS  Google Scholar 

  158. Grainge MJ et al (2009) The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer 100(1):178–180

    PubMed Central  PubMed  CAS  Google Scholar 

  159. Pandey M, Shukla M (2009) Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers. Surg Oncol 18(1):51–56

    PubMed  Google Scholar 

  160. Zabron A, Edwards RJ, and Khan SA (2013) The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms 6:281–292

    Google Scholar 

  161. IARC (2013) Ci5. Cancer incidence in five countries project. 2013 April 2013; graphs and tables of cancer incidence in 5 countries data. Available from: http://www.ci5.iarc.fr

  162. Levi F et al (2003) The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev 12(4):265–267

    PubMed  CAS  Google Scholar 

  163. Hariharan D, Saied A, Kocher HM (2008) Analysis of mortality rates for gallbladder cancer across the world. HPB (Oxford) 10(5):327–331

    CAS  Google Scholar 

  164. Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118(7):1591–1602

    PubMed  CAS  Google Scholar 

  165. Randi G et al (2009) Epidemiology of biliary tract cancers: an update. Ann Oncol 20(1):146–159

    PubMed  CAS  Google Scholar 

  166. Pandey M (2003) Risk factors for gallbladder cancer: a reappraisal. Eur J Cancer Prev 12(1):15–24

    PubMed  CAS  Google Scholar 

  167. Zatonski WA et al (1997) Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH program of the International Agency for Research on Cancer. J Natl Cancer Inst 89(15):1132–1138

    PubMed  CAS  Google Scholar 

  168. Diehl AK (1983) Gallstone size and the risk of gallbladder cancer. JAMA 250(17):2323–2326

    PubMed  CAS  Google Scholar 

  169. Lowenfels AB et al (1989) Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol 18(1):50–54

    PubMed  CAS  Google Scholar 

  170. Roa I et al (2006) Preneoplastic lesions in gallbladder cancer. J Surg Oncol 93(8):615–623

    PubMed  Google Scholar 

  171. Kwon W et al (2009) Clinicopathologic features of polypoid lesions of the gallbladder and risk factors of gallbladder cancer. J Korean Med Sci 24(3):481–487

    PubMed Central  PubMed  Google Scholar 

  172. Zielinski MD et al (2009) Comparison of surgically resected polypoid lesions of the gallbladder to their pre-operative ultrasound characteristics. J Gastrointest Surg 13(1):19–25

    PubMed  Google Scholar 

  173. Okamoto M et al (1999) Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am J Gastroenterol 94(2):446–450

    PubMed  CAS  Google Scholar 

  174. Welton JC, Marr JS, Friedman SM (1979) Association between hepatobiliary cancer and typhoid carrier state. Lancet 1(8120):791–794

    PubMed  CAS  Google Scholar 

  175. Caygill CP et al (1994) Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 343(8889):83–84

    PubMed  CAS  Google Scholar 

  176. Misra V et al (2007) Helicobacter pylori in areas of gastric metaplasia in the gallbladder and isolation of H. pylori DNA from gallstones. Pathology 39(4):419–424

    PubMed  CAS  Google Scholar 

  177. Sabbaghian MS et al (2010) Identification of helicobacter spp. in bile and gallbladder tissue of patients with symptomatic gallbladder disease. HPB (Oxford) 12(2):129–133

    Google Scholar 

  178. Lambe M et al (1993) Parity and cancers of the gall bladder and the extrahepatic bile ducts. Int J Cancer 54(6):941–944

    PubMed  CAS  Google Scholar 

  179. Pandey M, Shukla VK (2003) Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev 12(4):269–272

    PubMed  CAS  Google Scholar 

  180. Larsson SC, Wolk A (2007) Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 96(9):1457–1461

    PubMed Central  PubMed  CAS  Google Scholar 

  181. Strom BL et al (1995) Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 76(10):1747–1756

    PubMed  CAS  Google Scholar 

  182. Diehl AK, Beral V (1981) Cholecystectomy and changing mortality from gallbladder cancer. Lancet 2(8239):187–189

    PubMed  CAS  Google Scholar 

  183. Diehl AK (1987) Trends in cholecystectomy rates in the United States. Lancet 2(8560):683

    PubMed  CAS  Google Scholar 

  184. Ekbom A et al (1993) Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet 342(8882):1262–1265

    PubMed  CAS  Google Scholar 

  185. Wood R et al (2003) Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968–1998. Eur J Cancer 39(14):2080–2086

    PubMed  CAS  Google Scholar 

  186. Steinert R et al (2006) Laparoscopic cholecystectomy and gallbladder cancer. J Surg Oncol 93(8):682–689

    PubMed  Google Scholar 

  187. Dixon E et al (2005) An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 241(3):385–394

    PubMed Central  PubMed  Google Scholar 

  188. Kondo S et al (2008) Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg 15(1):41–54

    PubMed Central  PubMed  Google Scholar 

  189. Albores-Saavedra J et al (2011) Early gallbladder carcinoma: a clinicopathologic study of 13 cases of intramucosal carcinoma. Am J Clin Pathol 135(4):637–642

    PubMed  Google Scholar 

  190. Bartlett DL et al (1996) Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 224(5):639–646

    PubMed Central  PubMed  CAS  Google Scholar 

  191. Alberts SR et al (2005) Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Cancer 103(1):111–118

    PubMed  CAS  Google Scholar 

  192. Fong Y et al (2006) Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg 243(6):767–771 771–774

    PubMed Central  PubMed  Google Scholar 

  193. Taner CB, Nagorney DM, Donohue JH (2004) Surgical treatment of gallbladder cancer. J Gastrointest Surg 8(1):83–89 (discussion 89)

    PubMed  Google Scholar 

  194. Mayo SC et al (2010) National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg 14(10):1578–1591

    PubMed  Google Scholar 

  195. SEER, S.R.P., National Cancer Institute SEER/- Stat software, version 7.0.4. Faststats—SEER, Surveillance Research Program, National Cancer Institute SEER/- Stat software, version 7.0.4. 2013; Available from: http://www.seer.cancer.gov/faststats/

  196. Kiran RP, Pokala N, Dudrick SJ (2007) Incidence pattern and survival for gallbladder cancer over three decades—an analysis of 10301 patients. Ann Surg Oncol 14(2):827–832

    PubMed  CAS  Google Scholar 

  197. Donohue JH, Stewart AK, Menck HR (1998) The National Cancer Data Base report on carcinoma of the gallbladder, 1989–1995. Cancer 83(12):2618–2628

    PubMed  CAS  Google Scholar 

  198. Le MD et al (2011) Is gallbladder cancer decreasing in view of increasing laparoscopic cholecystectomy? Ann Hepatol 10(3):306–314

    PubMed  Google Scholar 

  199. Lemrow SM et al (2008) Gallbladder cancer incidence among American Indians and Alaska Natives, US, 1999–2004. Cancer 113(5):1266–1273

    PubMed  Google Scholar 

  200. Csendes A et al (2000) Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma: a prospective study of 592 cases. J Gastrointest Surg 4(5):481–485

    PubMed  CAS  Google Scholar 

  201. Renard P et al (1987) Biliary tract cancers in Cote-d’Or (France): incidence and natural history. J Epidemiol Community Health 41(4):344–348

    PubMed Central  PubMed  CAS  Google Scholar 

  202. Zatonski W et al (1993) Descriptive epidemiology of gall-bladder cancer in Europe. J Cancer Res Clin Oncol 119(3):165–171

    PubMed  CAS  Google Scholar 

  203. Khan MR et al (2011) Gallbladder intestinal metaplasia in Pakistani patients with gallstones. Int J Surg 9(6):482–485

    PubMed  Google Scholar 

  204. Wistuba II, Gazdar AF (2004) Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 4(9):695–706

    PubMed  CAS  Google Scholar 

  205. Kumar JR et al (2006) An objective assessment of demography of gallbladder cancer. J Surg Oncol 93(8):610–614

    PubMed  Google Scholar 

  206. Unisa S et al (2011) Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford) 13(2):117–125

    Google Scholar 

  207. Yagyu K et al (2008) Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan. Int J Cancer 122(4):924–929

    PubMed  CAS  Google Scholar 

  208. Lazcano-Ponce EC et al (2001) Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51(6):349–364

    PubMed  CAS  Google Scholar 

  209. Kimura K et al (1985) Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 89(6):1258–1265

    PubMed  CAS  Google Scholar 

  210. Alatise OI et al (2012) Audit of management of gallbladder cancer in a Nigerian tertiary health facility. J Gastrointest Cancer 43(3):472–480

    PubMed  CAS  Google Scholar 

  211. Hawkins WG et al (2004) Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 11(3):310–315

    PubMed  Google Scholar 

  212. Andia ME et al (2008) Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study. Int J Cancer 123(6):1411–1416

    PubMed Central  PubMed  CAS  Google Scholar 

  213. Carey MC, Paigen B (2002) Epidemiology of the American Indians’ burden and its likely genetic origins. Hepatology 36(4 Pt 1):781–791

    PubMed  CAS  Google Scholar 

  214. Everhart JE et al (1999) Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 117(3):632–639

    PubMed  CAS  Google Scholar 

  215. Everhart JE et al (2002) Prevalence of gallbladder disease in American Indian populations: findings from the strong heart study. Hepatology 35(6):1507–1512

    PubMed  Google Scholar 

  216. Mendez-Sanchez N et al (2004) The Amerindian’s genes in the Mexican population are associated with development of gallstone disease. Am J Gastroenterol 99(11):2166–2170

    PubMed  CAS  Google Scholar 

  217. Miyazaki M et al (2008) Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors. J Hepatobiliary Pancreat Surg 15(1):15–24

    PubMed Central  PubMed  Google Scholar 

  218. Shrikhande SV et al (2010) Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause! Eur J Surg Oncol 36(6):514–519

    PubMed  CAS  Google Scholar 

  219. Halldestam I, Kullman E, Borch K (2009) Incidence of and potential risk factors for gallstone disease in a general population sample. Br J Surg 96(11):1315–1322

    PubMed  CAS  Google Scholar 

  220. Shaffer EA (2005) Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 7(2):132–140

    PubMed  Google Scholar 

  221. Hsing AW et al (2007) Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 97(11):1577–1582

    PubMed Central  PubMed  CAS  Google Scholar 

  222. Hsing AW et al (2007) Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer 121(4):832–838

    PubMed Central  PubMed  CAS  Google Scholar 

  223. Tazuma S, Kajiyama G (2001) Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg 386(3):224–229

    PubMed  CAS  Google Scholar 

  224. Miquel JF et al (1998) Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 115(4):937–946

    PubMed  CAS  Google Scholar 

  225. Stephen AE, Berger DL (2001) Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery 129(6):699–703

    PubMed  CAS  Google Scholar 

  226. Chijiiwa K, Tanaka M (1994) Polypoid lesion of the gallbladder: indications of carcinoma and outcome after surgery for malignant polypoid lesion. Int Surg 79(2):106–109

    PubMed  CAS  Google Scholar 

  227. Dooley J, Sherlock S (2011) Sherlock’s diseases of the liver and biliary system, 12th edn. Wiley-Blackwell, Chichester, p 771 (xvi)

    Google Scholar 

  228. Kubota K et al (1995) How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery 117(5):481–487

    PubMed  CAS  Google Scholar 

  229. Lee KF et al (2004) Polypoid lesions of the gallbladder. Am J Surg 188(2):186–190

    PubMed  Google Scholar 

  230. Ito H et al (2009) Polypoid lesions of the gallbladder: diagnosis and followup. J Am Coll Surg 208(4):570–575

    PubMed  Google Scholar 

  231. Roa I et al (2010) Association between cholesterolosis and gallbladder cancer. Rev Med Chil 138(7):804–808

    PubMed  Google Scholar 

  232. Urbach DR, Stukel TA (2005) Rate of elective cholecystectomy and the incidence of severe gallstone disease. CMAJ 172(8):1015–1019

    PubMed Central  PubMed  Google Scholar 

  233. Whalen GF et al (2001) Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer. J Am Coll Surg 192(2):189–195

    PubMed  CAS  Google Scholar 

  234. de Aretxabala XA et al (2004) Laparoscopic cholecystectomy: its effect on the prognosis of patients with gallbladder cancer. World J Surg 28(6):544–547

    PubMed  Google Scholar 

  235. Fong Y, Heffernan N, Blumgart LH (1998) Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive resection is beneficial. Cancer 83(3):423–427

    PubMed  CAS  Google Scholar 

  236. Yamaguchi K et al (1996) Gallbladder carcinoma in the era of laparoscopic cholecystectomy. Arch Surg 131(9):981–984 (discussion 985)

    PubMed  CAS  Google Scholar 

  237. Varshney S, Butturini G, Gupta R (2002) Incidental carcinoma of the gallbladder. Eur J Surg Oncol 28(1):4–10

    PubMed  CAS  Google Scholar 

  238. Fuks D et al (2011) Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg 35(8):1887–1897

    PubMed  Google Scholar 

  239. Reid KM, Ramos-De la Medina A, Donohue H (2007) Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg 11(5):671–681

    PubMed  Google Scholar 

  240. Z’Graggen K et al (1998) Incidence of port site recurrence after laparoscopic cholecystectomy for preoperatively unsuspected gallbladder carcinoma. Surgery 124(5):831–838

    PubMed  Google Scholar 

  241. Misra MC, Guleria S (2006) Management of cancer gallbladder found as a surprise on a resected gallbladder specimen. J Surg Oncol 93(8):690–698

    PubMed  Google Scholar 

  242. Kao WY et al (2013) Risk of hepato-biliary cancer after cholecystectomy: a nationwide cohort study. J Gastrointest Surg 17(2):345–351

    PubMed  Google Scholar 

  243. Chow WH et al (1999) Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer 79(3–4):640–644

    PubMed Central  PubMed  CAS  Google Scholar 

  244. Chijiiwa K, Tanaka M, Nakayama F (1993) Adenocarcinoma of the gallbladder associated with anomalous pancreaticobiliary ductal junction. Am Surg 59(7):430–434

    PubMed  CAS  Google Scholar 

  245. Shimada K et al (1993) Biliary bile acids in the gall-bladder and the common bile duct of patients with anomalous pancreaticobiliary ductal junction. J Gastroenterol Hepatol 8(2):138–141

    PubMed  CAS  Google Scholar 

  246. Sugiyama Y et al (2000) Altered bile composition in the gallbladder and common bile duct of patients with anomalous pancreaticobiliary ductal junction. World J Surg 24(1):17–20 (discussion 21)

    PubMed  CAS  Google Scholar 

  247. Chao TC, Jan YY, Chen MF (1995) Primary carcinoma of the gallbladder associated with anomalous pancreaticobiliary ductal junction. J Clin Gastroenterol 21(4):306–308

    PubMed  CAS  Google Scholar 

  248. Funabiki T et al (1997) Biliary carcinogenesis in pancreaticobiliary maljunction. J Hep Bil Pancr Surg 4:405–411

    Google Scholar 

  249. Kang CM et al (2007) Gallbladder carcinoma associated with anomalous pancreaticobiliary duct junction. Can J Gastroenterol 21(6):383–387

    PubMed Central  PubMed  Google Scholar 

  250. Hu B, Gong B, Zhou DY (2003) Association of anomalous pancreaticobiliary ductal junction with gallbladder carcinoma in Chinese patients: an ERCP study. Gastrointest Endosc 57(4):541–545

    PubMed  Google Scholar 

  251. Kamisawa T et al (2002) Clinical significance of a long common channel. Pancreatology 2(2):122–128

    PubMed  Google Scholar 

  252. Mellemgaard A, Gaarslev K (1988) Risk of hepatobiliary cancer in carriers of Salmonella typhi. J Natl Cancer Inst 80(4):288

    PubMed  CAS  Google Scholar 

  253. Dutta U et al (2000) Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 95(3):784–787

    PubMed  CAS  Google Scholar 

  254. Fox JG et al (1998) Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114(4):755–763

    PubMed  CAS  Google Scholar 

  255. Chen W et al (2003) Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig Liver Dis 35(4):237–243

    PubMed  CAS  Google Scholar 

  256. Silva CP et al (2003) Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol 41(12):5615–5618

    PubMed Central  PubMed  Google Scholar 

  257. Blendis L (2005) What are Helicobacter doing in the hepatobiliary system? Gastroenterology 129(2):761–763

    PubMed  Google Scholar 

  258. Hsing AW et al (2008) Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 99(5):811–815

    PubMed Central  PubMed  CAS  Google Scholar 

  259. Pan WH et al (2004) Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 79(1):31–39

    PubMed  CAS  Google Scholar 

  260. Chang SC et al (2008) Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 29(5):944–948

    PubMed Central  PubMed  CAS  Google Scholar 

  261. Hemminki K, Li X (2003) Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut 52(4):592–596

    PubMed Central  PubMed  CAS  Google Scholar 

  262. Weiderpass E, Pukkala E (2006) Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland. BMC Gastroenterol 6:41

    PubMed Central  PubMed  Google Scholar 

  263. Serra I et al (2002) Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer 102(4):407–411

    PubMed  CAS  Google Scholar 

  264. Chow WH et al (1995) Smoking and biliary tract cancers in a cohort of US veterans. Br J Cancer 72(6):1556–1558

    PubMed Central  PubMed  CAS  Google Scholar 

  265. SEER, S.R.P., National Cancer Institute SEER/- Stat software, version 7.0.4. Surveillance, Epidemiology, and End Results (SEER) Program ( http://www.seer.cancer.gov ) SEER*Stat Database: Incidence—SEER 13 Regs Research Data, Nov 2011 Sub (1992–2009), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. 2013 April 2013]; SEER Incidence Data]. Available from: http://www.seer.cancer.gov

  266. SEER, S.R.P., National Cancer Institute SEER/- Stat software, version 7.0.4. US Mortality Data 1969–2010 when Using SEER*Stat: Surveillance, Epidemiology, and End Results (SEER) Program ( http://www.seer.cancer.gov ) SEER*Stat Database: Mortality—All COD, Aggregated With State, Total U.S. (1969-2010) <Katrina/Rita Population Adjustment> , National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013. Underlying mortality data provided by NCHS ( http://www.cdc.gov/nchs). 2013; Mortality data]. Available from: http://www.seer.cancer.gov

  267. Scotland ISDI, Scotland NNS (2012) Cancer in Scotland. 2012 April 2013; Available from: http://www.isdscotland.org/Health-Topics/Cancer/Cancer-Statistics/

  268. Andia KM, Gederlini GA, Ferreccio RC (2006) Gallbladder cancer: trend and risk distribution in Chile. Rev Med Chil 134(5):565–574

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hepatobiliary and Pancreas Surgery, Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK

    Ijeoma A. Azodo, Rowan W. Parks & O. James Garden

Authors
  1. Ijeoma A. Azodo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rowan W. Parks
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. James Garden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rowan W. Parks .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA

    Joseph M. Herman

  2. Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA

    Timothy M. Pawlik

  3. Department of Radiation Oncology, Oregon Health and Science University, Portland, Oregon, USA

    Charles R. Thomas, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Azodo, I.A., Parks, R.W., Garden, O.J. (2014). Epidemiology of Cholangiocarcinoma and Gallbladder Carcinoma. In: Herman, J., Pawlik, T., Thomas, Jr., C. (eds) Biliary Tract and Gallbladder Cancer. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40558-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40558-7_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40557-0

  • Online ISBN: 978-3-642-40558-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation